This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ryvu Therapeutics S.a.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: **Sylwia Sudol: Innovator in the Field of Biomedicine**
Introduction
Sylwia Sudol is a pioneering inventor based in Cracow, Poland, known for her contributions to the biomedical field. With a focus on advancing medical treatments, she has developed innovative compounds that have the potential to make significant impacts in therapeutic applications.
Latest Patents
Sylwia holds a patent for "Next-generation modulators of stimulator of interferon genes (STING)." This invention pertains to compounds of a specific formula, including their salts, stereoisomers, tautomers, or N-oxides that serve as modulators of STING (Stimulator of Interferon Genes). The patent highlights the compounds' utility as medicaments and in pharmaceutical compositions, showcasing a promising avenue for future medical therapies.
Career Highlights
Currently, Sylwia is affiliated with Ryvu Therapeutics S.A., a company dedicated to developing innovative therapeutics in the field of oncology. Her work in the company exemplifies her commitment to enhancing patient care through groundbreaking scientific research and development.
Collaborations
In her professional endeavors, Sylwia collaborates with esteemed colleagues, including Magdalena Izabela Zawadzka and Luigi Piero Stasi. These partnerships emphasize the importance of teamwork in advancing innovative ideas and driving success in the biomedical sector.
Conclusion
Sylwia Sudol's contributions to the field of biomedicine, particularly her patent related to STING modulators, mark her as a noteworthy inventor. Her work at Ryvu Therapeutics S.A. and collaboration with other prominent professionals further highlight her impact on innovation in healthcare. With continued research and development, she is poised to contribute significantly to the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile